Pyocin efficacy in a murine model of Pseudomonas aeruginosa sepsis
Author(s) -
Anne Six,
Khédidja Mosbahi,
Madhuri Barge,
Colin Kleanthous,
Thomas J. Evans,
Daniel Walker
Publication year - 2021
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkab199
Subject(s) - pseudomonas aeruginosa , sepsis , galleria mellonella , antibiotics , microbiology and biotechnology , in vivo , medicine , antimicrobial , biology , immunology , bacteria , virulence , gene , biochemistry , genetics
Bloodstream infections with antibiotic-resistant Pseudomonas aeruginosa are common and increasingly difficult to treat. Pyocins are naturally occurring protein antibiotics produced by P. aeruginosa that have potential for human use.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom